ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Ipsos

Ipsos (IPS)

45.06
-0.12
(-0.27%)
Cerrado 04 Noviembre 10:30AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
45.06
Postura de Compra
44.80
Postura de Venta
46.00
Volume Operado de la Acción
52,269
44.78 Rango del Día 45.38
44.78 Rango de 52 semanas 68.20
Capitalización de Mercado [m]
Precio Anterior
45.18
Precio de Apertura
44.82
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
52,009
Acciones en circulación
43,203,225
Rendimiento del Dividendo
3.66%
Ratio Precio/Utilidad
12.19
Beneficio por acción (BPA)
3.7
turnover
2.39B
Beneficio neto
159.73M

Acerca de Ipsos

Sector
Advertising Agencies
Industria
Advertising Agencies
Sitio web
Sede
Paris, Paris, Fra
Fundado
-
Ipsos is listed in the Advertising Agencies sector of the Euronext with ticker IPS. The last closing price for Ipsos was 45.18 €. Over the last year, Ipsos shares have traded in a share price range of 44.78 € to 68.20 €.

Ipsos currently has 43,203,225 shares in issue. The market capitalisation of Ipsos is 1.95 € billion. Ipsos has a price to earnings ratio (PE ratio) of 12.19.

IPS Últimas noticias

Ipsos : Déclaration mensuelle d'actions et de droits de vote - Septembre 2024

Ipsos : Déclaration mensuelle d'actions et de droits de vote - Septembre 2024 29 octobre 2024 PUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE...

Ipsos: Monthly declaration of shares and voting rights - September 2024

Ipsos: Monthly declaration of shares and voting rights - September 2024 October 29, 2024 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial...

Ipsos: Slowdown in activity in a more difficult business climate

Ipsos: Slowdown in activity in a more difficult business climate Slowdown in activity in a more difficult business climate Paris, October 24, 2024 - Ipsos, one of the world's leading market...

Ipsos: Slowdown in activity in a more difficult business climate

Slowdown in activity in a more difficult business climate Paris, October 24, 2024 - Ipsos, one of the world's leading market research companies, achieved a revenue of 591 million euros in the...

Ipsos : Ralentissement de l’activité dans un climat des affaires plus difficile

Ipsos : Ralentissement de l’activité dans un climat des affaires plus difficile Ralentissement de l’activité dans un climat des affaires plus difficile Paris, 24 octobre 2024 – Ipsos, l’une des...

Ipsos: Update on 2024 outlook

Ipsos: Update on 2024 outlook Update on 2024 outlook Revision of the annual organic growth target Maintenance of the operating margin target Paris, October 15, 2024 - Ipsos, one of the world's...

Ipsos : Actualisation des perspectives 2024

Ipsos : Actualisation des perspectives 2024 Actualisation des perspectives 2024 Révision de l’objectif annuel de croissance organique Maintien de l’objectif de marge opérationnelle Paris, 15...

Ipsos: Update on 2024 outlook

Update on 2024 outlook Revision of the annual organic growth target Maintenance of the operating margin target Paris, October 15, 2024 - Ipsos, one of the world's leading market research...

Ipsos : Déclaration mensuelle d'actions et de droits de vote - Août 2024

Ipsos : Déclaration mensuelle d'actions et de droits de vote - Août 2024 26 septembre 2024 PUBLICATION MENSUELLE DU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE...

Ipsos: Monthly declaration of shares and voting rights - August 2024

Ipsos: Monthly declaration of shares and voting rights - August 2024 September 26, 2024 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.62-1.3572679509645.6846.4444.786267245.67049199DE
4-11.54-20.388692579556.656.744.786902648.39361126DE
12-10.89-19.463806970555.9557.644.785200952.14902348DE
26-18.59-29.20659858663.6568.244.785517457.5958867DE
52-2.82-5.8897243107847.8868.244.785271058.80509041DE
1563.117.4135876042941.9568.236.15530451.32696627DE
26018.1167.198515769926.9568.215.825731741.94074754DE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALNEVNeovacs
0.0003 €
(50.00%)
26.06M
ALVIAVialife Sa
20.00 €
(42.86%)
50
EBUSEbusco Holding NV
2.7405 €
(29.57%)
884.29k
CNVCnova NV
0.13 €
(26.83%)
1.09k
MLFTIFrance Tourisme Immobilier
0.044 €
(25.71%)
300
ALALOAcheterLouerFR
0.70 €
(-65.00%)
14.37k
TMBSZTME Pharma NV
0.03 €
(-39.88%)
193.46k
ALAVEAventador
0.0012 €
(-33.33%)
43.98M
ALIMOGroupimo
0.20 €
(-31.51%)
39
NYRNyrstar NV
0.12 €
(-17.24%)
384.27k
BCPBanco Comercial Portugues SA
0.451 €
(-2.61%)
83.35M
ALAVEAventador
0.0012 €
(-33.33%)
43.98M
ALNEVNeovacs
0.0003 €
(50.00%)
26.06M
ALDOLDolfines
0.0005 €
(-16.67%)
22.5M
ALNRGEnergisme SA
0.0065 €
(-1.52%)
15.49M
ChannelTrader ChannelTrader 4 minutos hace
Oh my...lol
pinkslipjunkie pinkslipjunkie 4 minutos hace
I know what you are saying now and yes I see it all the time as well...yeah and you think does it bypass all the bids in between to do so and who gets those shares?
AFFU
AJH92 AJH92 5 minutos hace
$PSRU Overview - Updated November 3, 2024

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175326604

$PSRU Updates / PRs Expected - Updated November 3, 2024

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175326586
PSRU
HippyTrades HippyTrades 5 minutos hace
I'm 💯 safe because I don't buy said scams
PSRU
Buckey Buckey 5 minutos hace
yeah it had a pop then fizzled r/s coming so will likely flatten position by eod
zxjoshuaxz zxjoshuaxz 5 minutos hace
Back in the green!
FNMA
vinsterr vinsterr 5 minutos hace
Thanks it’s appreciated! No, nothing is happening it seems since the custodian discharge in May

To be continued…..
LLBO
blackcat blackcat 5 minutos hace
https://www.reuters.com/legal/facebook-nvidia-ask-us-supreme-court-spare-them-securities-fraud-suits-2024-11-04/
NVDA
misterfishman misterfishman 5 minutos hace
No lol
ASII
Lone Clone Lone Clone 5 minutos hace
Palamina Reports on Drilling at Sol De Oro East & Notes Multiple Visible Gold Intercepts at SDO South

https://www.newsfilecorp.com/release/228773/Palamina-Reports-on-Drilling-at-Sol-De-Oro-East-Notes-Multiple-Visible-Gold-Intercepts-at-SDO-South

November 04, 2024 9:32
getmoreshares getmoreshares 5 minutos hace
does it show amounts?
BCAP
Chartmaster Chartmaster 5 minutos hace
Chart is chugging along nicely here, support at 10's and resistance above 14's, ya gotta have FAITH! After election rally coming in ALL STOCKS!!! No fairy tale! You need to start hanging around a better quality people!
NBRI
mc73 mc73 5 minutos hace
Lucky? We will be under a dime soon. Not lucky unless you think losing money is lucky.

This company, at this point, might not have what it takes to get the IDE approved. Damn shame if they can't get it done
RDGL
$b_rich$ $b_rich$ 6 minutos hace
Everyone have a great week out there:)
Trooperstocks Trooperstocks 6 minutos hace
$COEP big news for the company, check it out: Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use https://finance.yahoo.com/news/coeptis-therapeutics-expands-license-agreement-120700632.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
COEP
surfkast surfkast 6 minutos hace
Thanks for proving my point about mindless responses instead of intelligent conversations about the company!
HIRU
dennisdave dennisdave 6 minutos hace
It's "efficacy", not "efficiency".

wrong

Efficacy trials (explanatory trials) determine whether an intervention produces the expected result under ideal circumstances. Effectiveness trials (pragmatic trials) measure the degree of beneficial effect under “real world” c
NWBO
Trooperstocks Trooperstocks 6 minutos hace
$COEP big news for the company, check it out: Coeptis Therapeutics Expands License Agreement with Deverra to Include Pandemic Preparedness, and Emergency Use https://finance.yahoo.com/news/coeptis-therapeutics-expands-license-agreement-120700632.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
COEP
blackhawks blackhawks 6 minutos hace
Republicans have an enormous dilemma to accompany their big sad when the Orange Felon loses, bigly.

Next, blame would be placed on a RW agenda, one that wandered off the smooth, paved road of enlightenment and rational thought, stumbled through the weeds, and then down the rabbit hole
CommodityCoverage CommodityCoverage 6 minutos hace
Amid U.S. election uncertainty, gold prices are continuing to rise with spot gold increasing 0.4% to $2,745.29 per ounce following last week's record high of $2,790.15. Investors are concerned about a contested result and political tensions with polls showing a close race and analysts including Bart
LUCMF
HippyTrades HippyTrades 6 minutos hace
Because you don't stop posting BS here
Anyone can spam a board to rise on the breakout board it's not rocket science 
PSRU
konshe konshe 6 minutos hace
Very possible. No any reasons going down except flippers sold it down. Hope big gap up with news coming.
RDGL
gemstone57 gemstone57 7 minutos hace
Sorry Adjusto your time limit has passed. For $500 in CASH we'll let you have another stab at it
MVNT
Konaploinks Konaploinks 7 minutos hace
No wonder the volume has been double lately
IONQ